Report cover image

Endologix LLC - Product Pipeline Analysis, 2023 Update

Publisher GlobalData
Published Aug 24, 2023
Length 48 Pages
SKU # GBDT18180188

Description

Summary


Endologix LLC (Endologix) is a medical equipment company that develops, manufactures and markets minimally invasive devices in treatment of aortic diseases. The company incorporates its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA) and ALTO Abdominal Stent Graft System. The company’s AAA products are built on traditional minimally invasive endovascular repair (EVAR) platform or endovascular sealing (EVAS) platform and Ovation system. The company’s EVAR products include AFX endovascular AAA system, the VELA proximal endograft, the ovation abdominal stent graft system. Its ALTO products are developed with adaptive sealing technology, low profile delivery system, and shortest neck indication system specialized for anatomies, including tortuous iliacs and short necks. It has manufacturing facility in Irvine and Santa Rosa, California. The company sells products in the US and six other countries through direct sales force. It also sells products through third-party distributors and agents in Asia Pacific, Latin America, Europe, and other targeted international geographies. Endologix is headquartered in Irvine, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Endologix LLC
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company

Table of Contents

48 Pages
Endologix LLC Company Overview
Endologix LLC Company Snapshot
Endologix LLC Pipeline Products and Ongoing Clinical Trials Overview
Endologix LLC – Pipeline Analysis Overview
Business Description
Endologix LLC - Key Facts
Endologix LLC - Major Products and Services
Endologix LLC Pipeline Products by Development Stage
Endologix LLC Ongoing Clinical Trials by Trial Status
Endologix LLC Pipeline Products Overview
AFX2 Bifurcated Endograft System
AFX2 Bifurcated Endograft System Product Overview
AFX3
AFX3 Product Overview
AFX4
AFX4 Product Overview
Nellix 3.5
Nellix 3.5 Product Overview
Nellix CHEVAS
Nellix CHEVAS Product Overview
Nellix CHEVAS Clinical Trial
Nellix EVAS System
Nellix EVAS System Product Overview
Nellix EVAS System Clinical Trial
Nellix With Snorkels
Nellix With Snorkels Product Overview
Next Gen EVAS
Next Gen EVAS Product Overview
Ovation Thoracic Stent Graft System
Ovation Thoracic Stent Graft System Product Overview
Paravisceral System
Paravisceral System Product Overview
PQ Crossing Device
PQ Crossing Device Product Overview
PQ Snare
PQ Snare Product Overview
TORUS Stent Graft System
TORUS Stent Graft System Product Overview
TORUS Stent Graft System Clinical Trial
Ventana 2
Ventana 2 Product Overview
Xpand BX Covered Stent
Xpand BX Covered Stent Product Overview
Endologix LLC - Key Competitors
Endologix LLC - Key Employees
Endologix LLC - Key Employee Biographies
Endologix LLC - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Endologix LLC, Recent Developments
Jul 05, 2020: Endologix enters into an agreement with Deerfield Partners to take the company private
May 11, 2020: Endologix, Inc. to Announce First Quarter 2020 Financial Results on May 11, 2020
Feb 19, 2020: Endologix reports fourth quarter and fiscal year 2019 financial results
Jan 10, 2020: PQ Bypass announces 100th patient in clinical study to evaluate percutaneous fem-pop bypass for extremely long blockages in leg arteries
Dec 19, 2019: CMS approves coverage for PQ Bypass TORUS 2 IDE trial
Nov 06, 2019: Endologix reports third quarter 2019 financial results
Nov 04, 2019: PQ Bypass initiates pivotal study of next-generation advancement in Stent Graft Technology for Treatment of Patients with Peripheral Artery Disease
Oct 29, 2019: Endologix comments on recent FDA update on Type III Endoleaks with AFX Endovascular AAA System
Oct 28, 2019: Update on risk of type III endoleaks with use of Endologix AFX Endovascular AAA Graft Systems: FDA safety communication
Oct 08, 2019: PQ Bypass announces unconditional IDE approval from U.S. FDA to start TORUS SFA Stent Graft Pivotal Study (TORUS-2)
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: Endologix LLC Pipeline Products and Ongoing Clinical Trials Overview
Table 2: Endologix LLC Pipeline Products by Equipment Type
Table 3: Endologix LLC Pipeline Products by Indication
Table 4: Endologix LLC, Key Facts
Table 5: Endologix LLC, Major Products and Services
Table 6: Endologix LLC Number of Pipeline Products by Development Stage
Table 7: Endologix LLC Pipeline Products Summary by Development Stage
Table 8: Endologix LLC Ongoing Clinical Trials by Trial Status
Table 9: Endologix LLC Ongoing Clinical Trials Summary
Table 10: AFX2 Bifurcated Endograft System - Product Status
Table 11: AFX2 Bifurcated Endograft System - Product Description
Table 12: AFX3 - Product Status
Table 13: AFX3 - Product Description
Table 14: AFX4 - Product Status
Table 15: AFX4 - Product Description
Table 16: Nellix 3.5 - Product Status
Table 17: Nellix 3.5 - Product Description
Table 18: Nellix CHEVAS - Product Status
Table 19: Nellix CHEVAS - Product Description
Table 20: Nellix CHEVAS - Prospective, Multicenter, Non-randomized Study with Consecutive, Eligible Subject Enrollment at Each Site, for the Evaluation of the ChEVAS System for Endovascular Repair of Paravisceral, Juxtarenal, and Pararenal Abdominal Aortic Aneurysms
Table 21: Nellix EVAS System - Product Status
Table 22: Nellix EVAS System - Product Description
Table 23: Nellix EVAS System - Multicenter, Observational, Registry to Assess Outcomes of Patients Treated With the CE Marked Nellix System for Endovascular Abdominal Aortic Aneurysm Repair
Table 24: Nellix EVAS System - Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix System IDE Study: EVAS 2 Confirmatory IDE Study
Table 25: Nellix With Snorkels - Product Status
Table 26: Nellix With Snorkels - Product Description
Table 27: Next Gen EVAS - Product Status
Table 28: Next Gen EVAS - Product Description
Table 29: Ovation Thoracic Stent Graft System - Product Status
Table 30: Ovation Thoracic Stent Graft System - Product Description
Table 31: Paravisceral System - Product Status
Table 32: Paravisceral System - Product Description
Table 33: PQ Crossing Device - Product Status
Table 34: PQ Crossing Device - Product Description
Table 35: PQ Snare - Product Status
Table 36: PQ Snare - Product Description
Table 37: TORUS Stent Graft System - Product Status
Table 38: TORUS Stent Graft System - Product Description
Table 39: TORUS Stent Graft System - Long Segment Lesion Peripheral Artery Revascularization Feasibility Study
Table 40: TORUS Stent Graft System - The PQ Bypass Pivotal IDE Intra-arterial Stent Graft Study for Occlusive and Re-stenotic Fem-pop Revascularization - 2 Trial: TORUS 2
Table 41: Ventana 2 - Product Status
Table 42: Ventana 2 - Product Description
Table 43: Xpand BX Covered Stent - Product Status
Table 44: Xpand BX Covered Stent - Product Description
Table 45: Endologix LLC, Key Employees
Table 46: Endologix LLC, Key Employee Biographies
Table 47: Endologix LLC, Subsidiaries
Table 48: Glossary
List of Figures
Figure 1: Endologix LLC Pipeline Products by Equipment Type
Figure 2: Endologix LLC Pipeline Products by Development Stage
Figure 3: Endologix LLC Ongoing Clinical Trials by Trial Status

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us